Related Experiment Video

Updated: Aug 20, 2025

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
07:05

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

528

Ubiquitin-specific protease 20 in human disease: Emerging role and therapeutic implications

Biying Qin1, Lihui Zhou1, Feng Wang1

  • 1Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing 100081, China.

Biochemical Pharmacology
|November 24, 2022
PubMed

Insights

Deubiquitinating enzymes (DUBs) like ubiquitin-specific protease 20 (USP20) regulate protein fate. USP20

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Homeostasis

Background:

  • Ubiquitination is a crucial post-translational modification regulating protein stability and cellular processes.
  • Deubiquitinating enzymes (DUBs) counteract ubiquitination, maintaining protein function and homeostasis.
  • Ubiquitin-specific protease 20 (USP20) is a DUB with emerging roles in various physiological and pathological contexts.

Purpose of the Study:

  • To review the structure, regulation, and physiological roles of USP20.
  • To highlight the therapeutic potential of USP20 in disease.
  • To discuss the implications of USP20 inhibition, exemplified by GSK2643943A.

Main Methods:

  • Literature review of studies on USP20.
  • Analysis of USP20's involvement in antiviral immunity, cancer, metabolic disorders, and neurological diseases.
  • Discussion of the inhibitory effects of small molecules like GSK2643943A on USP20 activity.

Main Results:

  • USP20 plays significant roles beyond its previously known functions in antiviral immunity and cancer.
  • Emerging evidence implicates USP20 in metabolic and neurological diseases.
  • The small molecule inhibitor GSK2643943A demonstrates the potential for targeting USP20's deubiquitination activity.

Conclusions:

  • USP20 is a critical regulator of protein fate with expanding implications in disease.
  • Targeting USP20 presents a promising therapeutic strategy for various disorders.
  • Further research into USP20's roles and inhibition is warranted for future therapeutic development.
Keywords:
Emerging physiological roleMolecular regulationStructure analysisTherapeutic implicationsUSP20

More Related Videos

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.1K
Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

5.6K

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.5K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K